Canopy Growth
Canopy’s net revenue plunges as challenges pile up in Canadian cannabis sector
Canopy Growth’s net revenue plunged 15% compared with the previous quarter, a development the Ontario-based company attributed to a “challenging” period in the Canadian cannabis sector marked by provincial wholesalers reducing purchases and disappointing retail store openings – particularly in its home province.
Cannabis producer Canopy downsizes Latin America workforce as region struggles to generate revenue
One of the largest cannabis companies in the world, Canopy Growth, is restructuring its overseas operations by laying off 15% of its workforce in Latin America, reflecting the slow pace at which revenue-generating opportunities and regulatory structures are evolving in the region.
Marijuana company Vireo Health wagers on former Canopy co-CEO Linton to expand nationally
To help expand its national footprint, multistate marijuana company Vireo Health International has hired Bruce Linton, one of the biggest names in the cannabis industry and former leader of Canada’s Canopy Growth until his surprise firing in the summer.
Danish medical cannabis sales stall on supply, price issues
Denmark’s medical cannabis pilot program saw virtually no quarter-over-quarter growth in the first half of 2019, according to new Danish Health Authority data.
Canada’s cannabis market ‘comes down to execution’: Q&A with marijuana entrepreneur Chuck Rifici
Chuck Rifici, CEO of Nesta Holding Co., discusses his insight into Canada’s cannabis market, business opportunities and shared advice for entrepreneurs.
Medical cannabis sales stall in Canada after adult-use legalization; affordability, access also considered factors
Monthly sales of medical cannabis in Canada dropped almost 25% in June from October 2018 – when adult use was legalized – according to the latest data from Health Canada.